A detailed history of Lpl Financial LLC transactions in Liquidia Corp stock. As of the latest transaction made, Lpl Financial LLC holds 28,100 shares of LQDA stock, worth $803,098. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,100
Previous 13,945 101.51%
Holding current value
$803,098
Previous $173,000 272.25%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$12.06 - $28.85 $170,709 - $408,371
14,155 Added 101.51%
28,100 $644,000
Q2 2025

Aug 12, 2025

SELL
$11.99 - $19.3 $5,695 - $9,167
-475 Reduced 3.29%
13,945 $173,000
Q1 2025

May 07, 2025

BUY
$11.36 - $16.5 $23,856 - $34,650
2,100 Added 17.05%
14,420 $212,000
Q4 2024

Feb 11, 2025

BUY
$9.82 - $11.8 $3,928 - $4,720
400 Added 3.36%
12,320 $144,000
Q3 2024

Nov 08, 2024

SELL
$8.9 - $14.11 $204,077 - $323,542
-22,930 Reduced 65.8%
11,920 $119,000
Q2 2024

Aug 07, 2024

BUY
$11.96 - $15.71 $416,806 - $547,493
34,850 New
34,850 $418,000

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $1.84B
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.